Testosterone 'normal ranges': what 300-1,000 ng/dL actually means

What's this video probably claiming?

Based on the caption and TRT-heavy hashtag stack, @alphagenics is almost certainly walking viewers through the standard testosterone reference range, the 300 to 1,000 ng/dL window that most labs use for adult men, and framing it as the baseline for deciding whether someone "needs" TRT. Given the Las Vegas weight loss hashtags running alongside the testosterone tags, there's a decent chance the video is also tying low testosterone to body composition struggles, which is a common funnel tactic for local hormone clinics. The implicit message is usually: if you're below 300 ng/dL, you're hypogonadal; if you're symptomatic and hovering near that floor, treatment is warranted. That framing isn't entirely wrong, but it papers over a lot of clinical complexity that the research community has been arguing about for years.

What does the science actually show?

The 300 ng/dL threshold gets thrown around as if it's a hard diagnostic cutoff, but the evidence behind it is shakier than most TRT content admits. The Endocrine Society's 2018 clinical practice guidelines, published in the Journal of Clinical Endocrinology and Metabolism, explicitly state that a diagnosis of hypogonadism requires both a consistently low testosterone level on at least two morning fasting measurements AND the presence of signs and symptoms. One number alone doesn't cut it. The reference range itself was largely derived from studies of young, healthy men, a point that Travison et al. (2017, JCEM) made when they noted that population-based normative data varies significantly by age, assay method, and the lab doing the testing. Liquid chromatography-mass spectrometry and immunoassay methods can return results that differ by 10 to 15 percent on the same sample. That's not a minor rounding error when your threshold is 300 ng/dL.

Where does the social media noise diverge from clinical reality?

TikTok TRT content almost universally treats the 300 ng/dL floor as a diagnosis-triggering threshold rather than a statistical artifact. It also tends to ignore the free testosterone question entirely. Total testosterone is what most consumer-facing content focuses on, but bioavailable and free testosterone, which account for sex hormone-binding globulin (SHBG) levels, are often more clinically relevant. A man with a total testosterone of 380 ng/dL and very high SHBG may have less biologically active hormone than someone at 290 ng/dL with low SHBG. The Bhasin et al. landmark paper in the New England Journal of Medicine (2001) and subsequent work from the same group showed that symptoms like fatigue, reduced libido, and decreased muscle mass start correlating meaningfully with testosterone only below roughly 200 to 250 ng/dL in most men, not 300. The gap between the clinical threshold and what wellness marketing implies is significant.

What should you actually know?

If you watch this video and come away thinking a single lab result determines whether you need TRT, that's the wrong takeaway. The American Urological Association guidelines and the Endocrine Society both require at least two separate morning blood draws showing consistently low levels before treatment is even considered. Morning timing matters because testosterone follows a diurnal rhythm, peaking between 7 and 10 a.m. and dropping by 20 to 35 percent by afternoon, per data from Brambilla et al. (2009, Clinical Endocrinology). Beyond the number, symptom burden matters. Bone density, sexual function, energy, and mood are all part of the clinical picture. And anyone framing TRT as a weight loss solution should know that the evidence there is modest at best. A 2013 Cochrane review found small reductions in fat mass with testosterone therapy, but the effects were not dramatic and varied considerably across studies. Context, symptoms, and a full hormone panel matter more than whether your total T clears an arbitrary floor.